'Allogeneic marrow transplantation in children with acute leukemia: A practice whose time has gone': Twenty years later

Leukemia

Volumn 23, Issue 12, 2009, Pages 2189-2196

  Pinkel, D ^a,b  

^a CALIFORNIA POLYTECHNIC STATE UNIVERSITY   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; ALLOTRANSPLANTATION; BONE MARROW TRANSPLANTATION; CHILD; EDITORIAL; HUMAN; INFANT; LEUKEMIA; METHODOLOGY; MORTALITY; RECURRENT DISEASE; SURVIVAL RATE; TREATMENT OUTCOME;

ACUTE DISEASE; BONE MARROW TRANSPLANTATION; CHILD; HUMANS; INFANT; LEUKEMIA; RECURRENCE; SURVIVAL RATE; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 74049127337     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2009.132     Document Type: Review

References (37)

1. Pinkel D. Allogeneic bone marrow transplantation in children with acute leukemia: a practice whose time has gone. Leukemia 1989; 3: 242-244. (Pubitemid 19073372)
2. Chessells J. A reply to D Pinkel, allogeneic bone marrow transplantation in childhood leukemia: another form of intensive treatment. Leukemia 1989; 3: 543-544.
3. Kersey JH. Reply to Donald Pinkel. Leukemia 1989; 3: 394-395.
4. Pinkel D. Bone marrow transplantation in children with acute leukemia: a 1990 view. Haematol.Bluttransf 1992; 35: 3-10.
5. Pinkel D. Bone marrow transplantation in children. J Peds 1993; 122: 331-341. (Pubitemid 23067209)
6. Deeg H. Bone marrow transplantation: A review of delayed complications. Br J Haematol 1984; 57: 185-208. (Pubitemid 14106394)
7. Sanders J, Pritchard S, Mahoney P, Amos D, Buckner D, Witherspoon R et al. Growth and development following marrow transplantation for leukemia. Blood 1986; 5: 1129-1135. (Pubitemid 17186392)
8. Hahn T, Wall D, Camitta B, Davies S, Dillon H, Gaynon P et al. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in children: An evidenced-based review. Biol Blood Bone Marrow Transplant 2005; 11: 823-861. (Pubitemid 41645639)
9. Pui C-H, Gaynon P, Boyett J, Chessells J, Baruchel A, Kamps W et al. Outcome of treatment in childhood acute lymphoblastic leukemia with rearrangements of the 11q23 chromosomal region. The Lancet 2002; 359: 1909-1915. (Pubitemid 34615770)
10. Chessells J, Harrison C, Watson S, Vora A, Richards S. Treatment of infants with lymphoblastic leukemia: results of the UK infant protocols 1987-1999. Br J Haematol 2002; 117: 306-314. (Pubitemid 34451145)
11. Pieters R, Schrappe M, De Lorenzo P, Hann I, De Rossi G, Felice M et al. A treatment protocol for infants younger than 1 year with acute lymphoblastic leukemia (Interfant-99): an observational study and a muticentre randomised trial. The Lancet 2007; 370: 240-250. (Pubitemid 47082422)
12. Balduzzi A, Valsecchi M, Uderzo C, De Lorenzo P, Klingebiel T, Peters C et al. Chemotherapy versus allogeneic transplantation in first complete remission for very high-risk childhood acute lymphoblastic leukemia in first complete remission: comparison by genetic randomization in an international prospective study. The Lancet 2005; 366: 635-642. (Pubitemid 41176015)
13. Arico M, Valsecchi M, Camitta B, Schrappe M, Chessells J, Baruchel A et al. Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia. N Engl J Med 2000; 342: 998-1006. (Pubitemid 30180646)
14. Arico M, Schrappe M, Hunger S, Carroll W, Conter V, Di Lorenzo P et al. Clinical outcome of 640 children with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia treated between 1995 and 2005. Blood (ASH annual meeting abstracts) 2008; 112. abstract 568.
15. Schultz K, Bowman WP, Slayton W, Aledo A, Devidas M, Sather H et al. Improved early event free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a Children's Oncology Group Study. J Clin Oncol (in press).
16. Nachman J, Heerema N, Sather H, Camitta B, Forestier E, Harrison C et al. Outcome of treatment in children with hypodiploid acute lymphoblastic leukemia. Blood 2007; 110: 1112-1115. (Pubitemid 47281405)
17. Nguyen K, Devidas M, Cheng S-C, La M, Raetz E, Carroll W et al. Factors influencing survival after relapse from acute lymphoblastic leukemia: A Children's Oncology Group Study. Leukemia 2008; 22: 2142-2150.
18. Lawson S, Harrison G, Richards S, Oakhill A, Stevens R, Eden O et al. The UK experience in treating relapsed childhood acute lymphoblastic leukemia: a report on the Medical Research Council UKALLR1 study. Br J Haematol 2000; 108: 31-543.
19. Eapen M, Raetz E, Zhang M-J, Muehlenbein C, Devidas M, Abshire T et al. Outcomes after HLA-matched sibling transplantation or chemotherapy in children with B-precursor acute lymphoblastic leukemia in a second remission: a collaborative study of the Children's Oncology Group and the Center for International Blood and Marrow Transplant Research. Blood 2006; 107: 4961-4967. (Pubitemid 43882651)
20. Einsiedel H, Von Stackelberg A, Hartmann R, Fengler R, Schrappe M, Janka-Schaub G et al. Long term outcome in children with relapsed ALL by risk-stratified salvage therapy: result of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Munster Group 87. J Clin Oncol 2005; 23: 7942-7950. (Pubitemid 46657394)
21. Schroeder H, Gustaffson G, Saarinen-Pikhala U, Glomstein A, Jonmundsson G, Nysom K et al. Allogeneic bone marrow transplantation in second remission of childhood acute lymphoblastic leukemia: a population-based case-control study from the Nordic countries. Bone Marrow Transplant 1999; 23: 555-560. (Pubitemid 29137443)
22. Saarinen-Pikhala U, Heilmann C, Winiarski J, Glomstein A, Abrahamsson J, Arvidson J et al. Pathways through relapses and deaths of children with acute lymphoblastic leukemia: role of allogeneic stem cell transplantation in Nordic data. J Clin Oncol 2006; 24: 5750-5762. (Pubitemid 46631318)
23. Roy A, Cargill A, Love S, Moorman A, Stoneham S, Lim A et al. Outcome after first relapse in childhood acute lymphoblastic leukemia-lessons from the United Kingdom R2 Trial. Br J Haematol 2005; 130: 67-75. (Pubitemid 40979134)
24. Malempati S, Gaynon P, Sather H, La M, Stork L. Outcome after relapse among children with standard risk acute lymphoblastic leukemia: Children's Oncology Group Study CCG-1952. J Clin Oncol 2007; 25: 5800-5807.
25. Gaynon P, Harris R, Altman A, Bostrom B, Breneman J, Hawks R et al. Bone marrow transplantation versus prolonged intensive chemotherapy for children with acute lymphoblastic leukemia and an initial bone marrow relapse within 12 months of the completion of primary therapy: Children's Oncology Group Study CCG-1941. J Clin Oncol 2006; 24: 3150-3156. (Pubitemid 46638953)
26. Woods W, Neudorf S, Gold S, Sanders J, Buckley J, Barnard D et al. A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission: a report from the Children's Cancer Group. Blood 2001; 97: 56-62. (Pubitemid 32061242)
27. Pinkel D. Letter to the editor: treatment of children with acute myeloid leukemia. Blood 2001; 97: 3673.
28. Gibson B, Wheatley K, Hann I, Stevens R, Webb D, Hills R et al. Treatment strategy and long term results in paediatric patients treated in consecutive UK AML trials. Leukemia 2005; 19: 2130-2138. (Pubitemid 41741605)
29. Lange B, Smith F, Feusner J, Barnard D, Dinndorf P, Feig S et al. Outcomes in CCG-2961, a Children's Oncology Group Phase 3 trial for untreated pediatric acute myeloid leukemia: A Report from the Children's Oncology Group. Blood 2008; 111: 1044-1053. (Pubitemid 351213382)
30. Creutzig U, Zimmerman M, Ritter J, Reinhardt D, Hermann J, Henze G et al. Treatment strategies and long term results in paediatric patients treated in four consecutive AML-BFM trials. Leukemia 2005; 19: 2030-2042. (Pubitemid 41741595)
31. Entz-Werle N, Suciu S, Van der Werff ten Bosch J, Vilmer E, Bertrand Y, Benoit Y et al. Results of 58872 and 58921 trials in acute myeloblastic leukemia and relative value of chemotherapy vs allogeneic bone marrow transplantation in first complete remission: The EORTC Children's Leukemia Group Report. Leukemia 2005; 19: 2072-2081. (Pubitemid 41741599)
32. Pession A, Rondelli R, Basso G, Rizzari C, Testi AM, Fagioli F et al. Treatment and long-term results in children with acute myeloid leukemia treated according to the AIEOP AML protocols. Leukemia 2005; 19: 2043-2053. (Pubitemid 41741596)
33. Thomas ED, Buckner C, Rudolph R, Fefer A, Storb R, Neiman P et al. Allogeneic marrow grafting for hematologic malignancy using HL-A matched donor recipient sibling pairs. Blood 1971; 38: 267-287.
34. Pui CH, Cheng C, Leung W, Rai S, Rivera G, Sandlund J et al. Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia. N Engl J Med 2003; 349: 640-649. (Pubitemid 36975996)
35. Manera R, Ramirez I, Mullins J, Pinkel D. Pilot studies of speciesspecific chemotherapy of childhood acute lymphoblastic leukemia using genotype and immunophenotype. Leukemia 2000; 14: 1354-1361. (Pubitemid 30599315)
36. Bhatia S, Francisco L, Carter A, Sun C-L, Baker KS, Gurney JG et al. Late mortality after allogeneic hematopoietic cell transplantation and functional status of long term survivors: Report from the Bone Marrow Transplant Survivor Study. Blood 2007; 110: 3784-3792. (Pubitemid 350159650)
37. Tichelli A. Comment: hematopoietic cell transplantation: a lifelong commitment. Blood 2007; 110: 3493-3494. (Pubitemid 350159608)